These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 34530886)

  • 41. Hemostatic defects in massive transfusion: an update and treatment recommendations.
    Napolitano LM
    Expert Rev Hematol; 2021 Feb; 14(2):219-239. PubMed ID: 33267678
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pilot Randomized trial of Fibrinogen in Trauma Haemorrhage (PRooF-iTH): study protocol for a randomized controlled trial.
    Steinmetz J; Sørensen AM; Henriksen HH; Lange T; Larsen CF; Johansson PI; Stensballe J
    Trials; 2016 Jul; 17(1):327. PubMed ID: 27430210
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Safety and efficacy assessment of allogeneic human dental pulp stem cells to treat patients with severe COVID-19: structured summary of a study protocol for a randomized controlled trial (Phase I / II).
    Ye Q; Wang H; Xia X; Zhou C; Liu Z; Xia ZE; Zhang Z; Zhao Y; Yehenala J; Wang S; Zhou G; Hu K; Wu B; Wu CT; Wang S; He Y
    Trials; 2020 Jun; 21(1):520. PubMed ID: 32532356
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Use of prothrombin complex concentrate as an adjunct to fresh frozen plasma shortens time to craniotomy in traumatic brain injury patients.
    Joseph B; Pandit V; Khalil M; Kulvatunyou N; Aziz H; Tang A; OʼKeeffe T; Hays D; Gries L; Lemole M; Friese RS; Rhee P
    Neurosurgery; 2015 May; 76(5):601-7; discussion 607. PubMed ID: 25886249
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Enhancement of the haemostatic effect of platelets in the presence of high normal concentrations of von Willebrand factor for critically ill patients needing platelet transfusion-a protocol for the will-plate randomised controlled trial.
    Herrmann G; Blum A; Bolliger D; Achermann R; Estermann A; Gebhard CE; Henn A; Huber J; Singh J; Todorov A; Zehnder T; Zellweger N; Buser A; Tsakiris DA; Hollinger A; Siegemund M
    Trials; 2023 Jan; 24(1):47. PubMed ID: 36670471
    [TBL] [Abstract][Full Text] [Related]  

  • 46. PragmaTic, prospEctive, randomized, controlled, double-blind, mulTi-centre, multinational study on the safety and efficacy of a 6% HydroxYethyl Starch (HES) solution versus an electrolyte solution in trauma patients: study protocol for the TETHYS study.
    Palma CD; Mamba M; Geldenhuys J; Fadahun O; Rossaint R; Zacharowski K; Brand M; Díaz-Cambronero Ó; Belda J; Westphal M; Brauer U; Dormann D; Dehnhardt T; Hernandez-Gonzalez M; Schmier S; de Korte D; Plani F; Buhre W
    Trials; 2022 Jun; 23(1):456. PubMed ID: 35655234
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Rational and design of the T-STORHM Study: A prospective randomized trial comparing fresh whole blood to blood components for acutely bleeding trauma patients.
    Martinaud C; Tiberghien P; Bégué S; Sailliol A; Gross S; Pouget T; Ausset S
    Transfus Clin Biol; 2019 Nov; 26(4):198-201. PubMed ID: 31645305
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Endogenous thrombin potential following hemostatic therapy with 4-factor prothrombin complex concentrate: a 7-day observational study of trauma patients.
    Schöchl H; Voelckel W; Maegele M; Kirchmair L; Schlimp CJ
    Crit Care; 2014 Jul; 18(4):R147. PubMed ID: 25008277
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prothrombin complex concentrate versus fresh-frozen plasma for reversal of coagulopathy of trauma: is there a difference?
    Joseph B; Aziz H; Pandit V; Hays D; Kulvatunyou N; Yousuf Z; Tang A; O'Keeffe T; Green D; Friese RS; Rhee P
    World J Surg; 2014 Aug; 38(8):1875-81. PubMed ID: 24798029
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of a fixed-ratio (1:1:1) transfusion protocol versus laboratory-results-guided transfusion in patients with severe trauma: a randomized feasibility trial.
    Nascimento B; Callum J; Tien H; Rubenfeld G; Pinto R; Lin Y; Rizoli S
    CMAJ; 2013 Sep; 185(12):E583-9. PubMed ID: 23857856
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Association between viscoelastic tests-guided therapy with synthetic factor concentrates and allogenic blood transfusion in liver transplantation: a before-after study.
    Zamper RPC; Amorim TC; Queiroz VNF; Lira JDO; Costa LGV; Takaoka F; Juffermans NP; Neto AS
    BMC Anesthesiol; 2018 Dec; 18(1):198. PubMed ID: 30579327
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
    Akova M; Unal S
    Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A prospective, randomized, controlled study assessing vagus nerve stimulation using the gammaCore®-Sapphire device for patients with moderate to severe CoViD-19 Respiratory Symptoms (SAVIOR): A structured summary of a study protocol for a randomised controlled trial".
    Tornero C; Vallejo R; Cedeño D; Orduña J; Pastor E; Belaouchi M; Escamilla B; Laredo M; Del Mar Garzando M
    Trials; 2020 Jun; 21(1):576. PubMed ID: 32586395
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prothrombin complex concentrate in trauma patients.
    Matsushima K; Benjamin E; Demetriades D
    Am J Surg; 2015 Feb; 209(2):413-7. PubMed ID: 25457236
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Normalization of blood clotting characteristics using prothrombin complex concentrate, fibrinogen and FXIII in an albumin based fluid: experimental studies in thromboelastometry.
    Koller T; Kinast N; Castellanos AG; Garcia SP; Iglesias PP; Vintro XL; Arranz JM; Seto NV; García MVM; Moreno-Castaño AB; Aznar-Salatti J; Albaladejo GE; Diaz-Ricart M
    Scand J Trauma Resusc Emerg Med; 2021 Apr; 29(1):57. PubMed ID: 33836790
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prothrombin complex concentrate versus recombinant factor VIIa for reversal of hemodilutional coagulopathy in a porcine trauma model.
    Dickneite G; Dörr B; Kaspereit F; Tanaka KA
    J Trauma; 2010 May; 68(5):1151-7. PubMed ID: 19996804
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Andexanet alfa versus four-factor prothrombin complex concentrate for the reversal of apixaban- or rivaroxaban-associated intracranial hemorrhages.
    Pham H; Medford WG; Horst S; Levesque M; Ragoonanan D; Price C; Colbassani H; Piper K; Chastain K
    Am J Emerg Med; 2022 May; 55():38-44. PubMed ID: 35272069
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Inactivated Four-Factor Prothrombin Complex Concentrate Dosing Practices for Reversal of Warfarin-Related Intracranial Hemorrhage.
    Rhoney DH; La M; Merz M; Cook A; Owusu KA; Roels C; Blunck J; Shewmaker J; Sangha KS; Farrokh S; Lewin J; Chester KW; Human T; Bledsoe K; Greene K; Levesque M; Rocker JC; Davis G; Neyens R; Lassiter TF; Adriance SM
    Neurocrit Care; 2021 Aug; 35(1):130-138. PubMed ID: 33219462
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Therapy of trauma-induced coagulopathy - what is the evidence?].
    Guth MC; Kaufner L; Kleber C; von Heymann C
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2012 Sep; 47(9):528-39; quiz 540. PubMed ID: 22968981
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The CRYOSTAT2 trial: The rationale and study protocol for a multi-Centre, randomised, controlled trial evaluating the effects of early high-dose cryoprecipitate in adult patients with major trauma haemorrhage requiring major haemorrhage protocol activation.
    Curry N; Davenport R; Lucas J; Deary A; Benger J; Edwards A; Evans A; Foley C; Green L; Morris S; Thomas H; Brohi K; Stanworth SJ
    Transfus Med; 2023 Apr; 33(2):123-131. PubMed ID: 36321753
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.